DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Angiogenesis inhibitor
Angiogenesis inhibitor
Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities
MINIREVIEW Complex Role of Matrix Metalloproteinases in Angiogen- Esis
Integrins: Roles in Cancer Development and As Treatment Targets
Matrix Metalloproteinases in Angiogenesis: a Moving Target for Therapeutic Intervention
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
C11, a Novel Fibroblast Growth Factor Receptor 1 (FGFR1)
An Angiogenesis Inhibitor
Angiogenesis Inhibitor Induced Thromboembolism in Cancer Patients Neeharik Mareedu and Carmen P Escalante*
Overview on the Different Patterns of Tumor Vascularization
Integrins As Therapeutic Targets: Successes and Cancers
Endogenous Inhibitors of Angiogenesis in Malignant Gliomas: Nature’S Antiangiogenic Therapy1
Approaching Angiogenesis
Angiogenesis Inhibitors for Cancer Therapy
Fibroblast Growth Factor Receptor Inhibitors As a Cancer Treatment: from a Biologic Rationale to Medical Perspectives
The Extracellular Matrix and VEGF Processing
Endogenous Inhibitors of Angiogenesis
Endostatin Lowers Blood Pressure Via Nitric Oxide and Prevents Hypertension Associated with VEGF Inhibition
Angiogenesis Inhibitors As Anti-Cancer Therapy Following Renal Transplantation: a Case Report and Review of the Literature
Top View
Suppression of Angiogenesis and Tumor Growth by the Inhibitor K1–5 Generated by Plasmin-Mediated Proteolysis (Angiostatin͞plasminogen͞antitumor)
Exosomes in Angiogenesis and Anti-Angiogenic Therapy in Cancers
Matrikine and Matricellular Regulators of EGF Receptor Signaling on Cancer Cell Migration and Invasion Jelena Grahovac and Alan Wells
Antiangiogenic and Anticancer Molecules in Cartilage Debabrata Patra Washington University School of Medicine in St
Targeting Fibroblast Growth Factor Receptor (FGFR) Pathway in Renal Cell Carcinoma
Endostatin Reduces Vascularization, Blood Flow, and Growth in a Rat Gliosarcoma
Angiostatin and Anti-Angiogenic Therapy in Human Disease
Prevents Acquired Tumor Resistance to Angiostatin Gene Therapy
New Angiogenic Regulators Produced by Tams: Perspective for Targeting Tumor Angiogenesis
Angiogenesis by Fibroblast Growth Factor 4 Is Mediated Through an Autocrine Up-Regulation of Vascular Endothelial Growth Factor Expression1
Integrins and Extracellular Matrix
Anlotinib: a Novel Multi-Targeting Tyrosine Kinase Inhibitor in Clinical Development
The in Vivo Properties of STX243: a Potent Angiogenesis Inhibitor in Breast Cancer
Evaluation of Efficacy and Safety Markers in a Phase II Study of Metastatic Colorectal Cancer Treated with Aflibercept in the First-Line Setting
An Angiogenesis Inhibitor E7820 Shows Broad-Spectrum Tumor Growth Inhibition in a Xenograft Model: Possible Value of Integrin ␣2 on Platelets As a Biological Marker
Hoofdstuk Proteases and Angiogenesis
2-Methoxyestradiol Inhibits Experimental Autoimmune Encephalomyelitis Through Suppression of Immune Cell Activation
VEGF and Tumor Angiogenesis
Nephrotoxicity of Anti-Angiogenic Therapies
Does Imaging Avb3 Integrin Expression with PET Detect Changes in Angiogenesis During Bevacizumab Therapy?
Endostatin: an Endogenous Inhibitor of Angiogenesis and Tumor Growth
High Level of Stabilized Angiostatin Mediated by Adenovirus Delivery Does Not Impair the Growth of Human Neuroblastoma Xenograft
Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma
Quantitative Gene-Expression of the Tumor Angiogenesis Markers
An Angiogenesis Inhibitor, 2-Methoxyestradiol, Involutes Rat Collagen-Induced Arthritis and Suppresses Gene Expression of Synovi
The Vascular Endothelial Growth Factor Receptor Tyrosine Kinase
The Tyrosine Kinase Inhibitor, AZD2171, Inhibits Vascular Endothelial Growth Factor Receptor Signaling and Growth of Anaplastic
Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas Via Dual Targeting Of
The Role of VEGF Receptors As Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy
Preliminary Clinical Assessment of the Relationship Between Tumor Alphavbeta3 Integrin and Perfusion in Patients Studied With
Exploring the Therapeutic Rationale for Angiogenesis Blockade in Cervical Cancer
Landscape and Targeting of the Angpt-Tie System in Current Anticancer Therapy
Therapeutic Anti-Angiogenesis for Malignant Brain Tumors
Effect of VEGF Receptor Inhibitor PTK787/ZK222548 Combined with Ionizing Radiation on Endothelial Cells and Tumour Growth
VU Research Portal
Extracellular Matrix, Inflammation, and the Angiogenic Response
Newly Discovered Angiogenesis Inhibitors and Their Mechanisms of Action
Evaluation of Endostatin Antiangiogenesis Gene Therapy in Vitro and in Vivo
SPARC Is a Key Schwannian-Derived Inhibitor Controlling Neuroblastoma Tumor Angiogenesis1
Bevacizumab Treatment of Meningeal Melanoma Metastases Trude G